Dergiler / Infectious diseases and clinical microbiology (Online) / 2021 / Cilt: 3 - Sayı: 1

The Impact of SARS-CoV-2 variants on Morbidity,Mortality and Effectiveness of Vaccines

Sayfa
48–51
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

MİDİLLİ, K. (2022). The Impact of SARS-CoV-2 variants on Morbidity,Mortality and Effectiveness of Vaccines. Infectious diseases and clinical microbiology (Online), Cilt: 3 - Sayı: 1, 48–51. https://ajindex.com/articles/539071

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (3)

  1. 1 Arora P, Pöhlmann S, Hoffmann M. Mutation D614G increases SARS-CoV-2 transmission. Sig Transduct Target Ther 2021
  2. 2 Centers for Disease Control and Prevention (CDC). SARSCoV-2 Variant Classifications and Definitions. 2021 Apr 27 (cited 2021 Apr 27). Available from: https://www.cdc.gov/ coronavirus/2019-ncov/cases-updates/variant-surveillance/ variant-info.html 3 Di Caro A, Cunha F, Petrosillo N, Beeching NJ, Ergonul O, Petersen E, et al. SARS-CoV-2 escape mutants and protective immunity from natural infections or immunizations. Clini Microbiol Infect 2021: S1198-743X(21)00146-4. [Epub ahead of print]. 4 Public Health England. Investigation of novel SARS-CoV-2 variant. Variant of Concern 202012/01. 2020 Dec (cited 2021 Apr 27). Available from: https://assets.publishing.service.gov. uk/government/uploads/system/uploads/attachment_data/ file/959361/Technical_Briefing_VOC202012-2_Briefing_2.pdf 5 Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv 2020.12.21.20248640. 6 Sabino EC, Buss LF, Carvalho MPS, Prete CA Jr, Crispim MAE, Fraiji NA, et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet 2021
  3. 7 Faria NR, Mellan TA, Whittaker C, Claro IM, Candido DDS, Mishra S, Crispim MAE, et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science 2021: eabh2644. [Epub ahead of print] 8 Dejnirattisai W, Zhou D, Supasa P, Liu C, Mongkolsapaya J, Ren J, et al. Antibody evasion by the P.1 strain of SARS-CoV-2. Cell 2021: S0092-8674(21)00428-1. [Epub ahead of print] 9 World Health Organization (WHO). SARS-CoV-2 genomic sequencing for public health goals: interim guidance, 8 January 2021. 2021 (cited 2021 Apr 27). Available from: https://apps. who.int/iris/handle/10665/338483 10 European Centre for Disease Prevention and Control (ECDC). Sequencing of SARS-CoV-2 - first update. 2021 Jan 18 (cited 2021 Apr 27). Available from: https://www.ecdc.europa.eu/en/ publications-data/sequencing-sars-cov-2 11 Centers for Disease Control and Prevention (CDC). Genomic Surveillance for SARS-CoV-2 Variants. 2021 (cited 2021 Apr 27). Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance.html 12 Huang B, Dai L, Wang H, Hu Z, Yang X, Tan W, et al. Serum sample neutralisation